Author

E. Preto

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. O. Bigogno· 1 shared C. B. Nava Lauson· 1 shared E. Ceccaci· 1 shared E. Sala· 1 shared I. Pallavicini· 1 shared L. Nezi· 1 shared M. Iannacone· 1 shared M. Kuka· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. O. Bigogno

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsiveness.

I. Pallavicini, T. M. Frasconi, E. Ceccaci, S. Tiberti, C. B. Nava Lauson, E. Preto, A. O. Bigogno, M. Mangione, E. Sala, M. Iannacone, M. Kuka, L. Nezi, S. Minucci, T. Manzo

This study shows that inhibiting LSD1 enhances CD8+ T cell function in adoptive T cell therapy, leading to improved antitumor immunity and synergistic effects with anti-PDL1 therapy.

bioRxiv · Oct 27, 2023Immunology